Ameliorative potential of S-allylcysteine: Effect on lipid profile and changes in tissue fatty acid composition in experimental diabetes

Experimental and Toxicologic Pathology

Volumn 64, Issue 6, 2012, Pages 639-644

  Saravanan, Ganapathy ^a,b   Ponmurugan, Ponnusamy ^a,c  

^a BHARATHIAR UNIVERSITY   (India)

^b K S RANGASAMY COLLEGE OF ARTS AND SCIENCE AUTONOMOUS   (India)

^c K S RANGASAMY COLLEGE OF TECHNOLOGY   (India)

Author keywords

Antidiabetic effect; Diabetes mellitus; Lipid; S allylcysteine; SAC; Streptozotocin; STZ

Indexed keywords

ARACHIDONIC ACID; FATTY ACID; GLICLAZIDE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LINOLENIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OLEIC ACID; PALMITIC ACID; PHOSPHOLIPID; S ALLYLCYSTEINE; STEARIC ACID; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ANTIHYPERLIPIDEMIC EFFECT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DRUG ACTIVITY; FATTY ACID BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HYPERLIPIDEMIA; KIDNEY; LIPID COMPOSITION; LIPID LIVER LEVEL; LIVER; MALE; NONHUMAN; PHOSPHOLIPID BLOOD LEVEL; RAT; STREPTOZOCIN DIABETES; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; CYSTEINE; DIABETES MELLITUS, EXPERIMENTAL; FATTY ACIDS; HYPOGLYCEMIC AGENTS; LIPIDS; MALE; RATS; RATS, WISTAR;

RATTUS;

EID: 84864524850     PISSN: 09402993     EISSN: 16181433     Source Type: Journal    
DOI: 10.1016/j.etp.2010.12.007     Document Type: Article

References (50)

1. Agardh C.D., Bjorgell P., Nilson E.P. The effect of tolbutamide on lipoproteins, and lipoproteinlipase and hormone sensitive lipase. Diabetes Res Clin Pract 1999, 46:99-108.
2. Bagdade J.D., Helve E., Taskinen M.R. Effect of continuous insulin infusion therapy lipoprotein surface and core lipid composition in IDDM. Metabolism 1991, 40:445-449.
3. Block E. The organosulfur chemistry of the genus allium: implications for the organic chemistry of sulfur. Angew Chem Int Ed 1992, 31:1135-1178.
4. Bopanna K.N., Kannan J., Sushma G., Balaraman R., Rathod S.P. Antidiabetic and anti hyperlipaemic effects of neem seed kernel powder on alloxan diabetic rabbits. Indian J Pharmacol 1997, 29:162-167.
5. Cameron N.E., Cottter M.A. Effects of antioxidants on nerve and vascular dysfunction in experimental diabetes. Diabetes Res Clin Pract 1997, 45:137-146.
6. Chisolm G.M., Irwin K.C., Penn M.S. Lipoprotein oxidation and lipoprotein induced cell injury in diabetes. Diabetes 1992, 41(2):61-66.
7. Deedwania P.C., Hunninghake D.B., Bays H. Effects of lipid-altering treatment in diabetes mellitus and metabolic syndrome. Am J Cardiol 2004, 93:18C-20C.
8. Falholt K., Falholt W., Lund B. An easy colorimetric method for routine determination of free fatty acids in plasma. Clin Chim Acta 1973, 46:105-111.
9. Fiske C.H., Subbarow Y. The colorimetric determination of phosphorus. J Biol Chem 1925, 66:375-400.
10. Folch J., Lees M., Solane S.G.H. A simple method for isolation and purification of total lipids from animal tissues. J Biol Chem 1957, 226:497-509.
11. Folsom A.R., Ma J., Mc Govern P.G., Eckfeldt H. Relation between phospholipids, saturated fatty acids and hyperinsulinemia. Metabolism Clin Exp 1996, 45:223-228.
12. Fossati P., Lorenzo P. Serum triglycerides determined calorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem 1982, 28:2077-2080.
13. Frayn K.N. Insulin resistance and lipid metabolism. Curr Opin Lipidol 1993, 4:197-204.
14. Gayathri M., Kannabiran K. Antidiabetic and ameliorative potential of ficus bengalensis bark extract in streptozotocin induced diabetic rats. Indian J Clin Biochem 2008, 23:394-400.
15. Goldberg R.B. Lipid disorders in diabetes. Diabetes Care 1981, 4:561-572.
16. Guijarro C., Kasiske B.L., Kim Y, O'Donnell M., Lee S.H., Keane W.F. Early glomerular changes in rats with dietary-induced hypercholesterolemia. Am J Kidney Dis 1995, 26:152-161.
17. Ivorra M.D., Paya M., Villar A. A review of natural products and plants as potential antidiabetic drugs. J Ethnopharmacol 1989, 27:243-275.
18. Jacot E., Assal J.P.H. Regulation de la glycemie. Pharmacologiedes Concepts Fondamentaux aux Applications Therapeutiques 1989, 481-494. Frison-Roche et Slatkine. Schorderet (Ed.).
19. Kaleem M., Asif M., Ahmed Q., Bano B. Antidiabetic and antioxidant activity of Annona squamosa extract in streptozotocin induced diabetic rats. Singapore Med J 2006, 47:670-675.
20. King H., Aubert R.E., Herman W.H. Global burden of diabetes 1995-2025: prevalence, numerical estimates and projections. Diabetes Care 1998, 21:1414-1431.
21. Larson M.O., Wilken M., Gotfredsen C.F., Carr R.D., Svendsen O., Rolin B. Mild streptozotocin diabetes in the Gottingen minipig. A novel model of moderate insulin deficiency and diabetes. Am J Physiol Endocrinol Metab 2002, 282:1342-1351.
22. Lee H.B., Cha M.K., Song K.I., Kim J.H., Lee E.Y., Kim S.I., et al. Pathogenic role of advanced glycosylation end products in diabetic nephropathy. Kidney Int 1997, 52:S60-S65.
23. Lehto S., Haffner S.M., Pyorala K., Kallio V., Laakso M. Dyslipidemia and hyperglycemia predict coronary heart disease events in middle-aged patients with NIDDM. Diabetes 1997, 46:1354-1359.
24. Marles R.J., Farnsworth N.R. Antidiabetic plants and their active constituents. Phytomedicine 1995, 2:137-189.
25. Mohan V., Madan Z., Jha R., Deepa R., Pradeepa R. Diabetes - social and economic perspectives in the new millennium. Int J Diabetes Dev Ctries 2004, 24:29-35.
26. Moller D.E. New drug targets for type 2 diabetes and the metabolic syndrome: a review. Nature 2001, 414:821-827.
27. Morrison W.R., Smith L.M. Preparations of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride methanol. J Lipid Res 1964, 5:600-607.
28. Murugan P., Pari L. Protective role of tetrahydrocurcumin on changes in the fatty acid composition in streptozotocin-nicotinamide induced type 2 diabetic rats. J Appl Biomed 2007, 5:31-38.
29. Muruganandan S., Srinivasan K., Gupta S., Gupta P.K., Lal J. Effect of mangiferin on hyperglycemia and atherogenicity in streptozotocin diabetic rats. J Ethnopharmacol 2005, 97:497-501.
30. Numagami Y., Ohnishi S.T. S-allylcysteine inhibits free radical production, lipid peroxidation and neuronal damage in rat brain ischemia. J Nutr 2001, 131:1100-1105.
31. Ogbonnia S.O., Odimegwu J.I., Enwuru V.N. Evaluation of hypoglycaemic and hypolipidaemic effects of aqueous ethanolic extracts of Treculia africana Decne and Bryophyllum pinnatum Lam. and their mixture on streptozotocin (STZ)-induced diabetic rats. Afr J Biotechnol 2008, 7:2535-2539.
32. Palsamy P., Subramanian S. Resveratrol, a natural phytoalexin, normalizes hyperglycemia in streptozotocin-nicotinamide induced experimental diabetic rats. Biomed Pharmacother 2008, 62:598-605.
33. Pelikanova T., Kohout M., Valek J., Base J., Stefka Z. Fatty acid composition of serum lipids and erythrocyte membranes in type 2 (non-insulindependent) diabetic men. Metabolism 1991, 40:175-180.
34. Pulido N., Suarez A., Casanova B., Romero R., Rodriguez E., Rovira A. Glyclazide treatment of streptozotocin diabetic rats restores GLUT4 protein content and basal glucose uptake in skeletal muscle. Metabolism 1997, 46:10-13.
35. Pushparaj P., Tan C.H., Tan B.K.H. Effects of Averrhoa bilimli leaf extract on blood glucose and lipids in streptozotocin diabetic rats. J Ethnopharmacol 2000, 72:69-76.
36. Rakieten N., Rakieten M.L., Nadkarni M.V. Diabetogenic action of streptozotocin. Proc Soc Exp Biol Med 1967, 126:201-205.
37. Raju J., Gupta D., Rao A.R., Yadava P.K., Baquer N.Z. Trigonella foenumgraecum seed powder improves glucose homeostasis in alloxan diabetic rat tissues by reversing the altered glycolytic, gluconeogenic and lipogenic enzymes. Mol Cell Biochem 2001, 224:45-51.
38. Rates S.M. Plants as source of drugs. Toxicon 2001, 39:603-613.
39. Ravi P., Dai S., Tam K.C. Synthesis and self assembly of [6O] fullerene containing sulfobetaine polymer in aqueous solution. J Phys Chem B Condens Matter Mater Surf Interfaces Biophys 2005, 8:22791-22798.
40. Saravanan G., Ponmurugan P., Senthil kumar G.P., Rajarajan T. Antidiabetic properties of S-allyl cysteine, a garlic component on streptozotocin-induced diabetes in rats. J Appl Biomed 2009, 7:151-159.
41. Saravanan G., Ponmurugan P., Senthil kumar G.P., Rajarajan T. Modulatory effect of S-allylcysteine on glucose metabolism in streptozotocin induced diabetic rats. J Func Foods 2009, 1:336-340.
42. Scheen J.A. Drug treatment of non-insulin dependent diabetes mellitus in the 1990. Achievement and future development. Drug 1997, 54:355-368.
43. Shanmugasundram E.R.B., Gopinath K.L., Shanmugasundram K.R., Rajendran V.M. Possible regeneration of islets of langerhans in streptozotocin diabetic rats given Gymnema sylvestre leaf extract. J Ethnopharmacol 1990, 30:265-279.
44. Shew W.H., Jeng C.Y., Lee W.J., Lin S.Y., Pei D., Chen Y.T. Simvastatin treatment in postprandial hypertriglyceridemia in type 2 diabetes mellitus patients with combined hyperlipidemia. Metabolism 2001, 50:355-359.
45. Srinivasan K., Ramarao P. Animal model in type 2 diabetes: an overview. Indian J Med Res 2007, 125:451-472.
46. Sun L., Halaihel N., Zhang W., Rogers T., Levi M. Role of sterol regulatory element-binding protein 1 in regulation of renal lipid metabolism and glomerulosclerosis in diabetes mellitus. J Biol Chem 2002, 277:18919-18927.
47. Vessby B. Dietary fat and insulin actions in humans. Br J Nutr 2000, 83:91-96.
48. World Health Organization. WHO launches the first global strategy on traditional and alternative medicine. WHO Press release; 2002, p. 38: http://www.who.int/mediacentre/news/release/release38/en.
49. Zilversmit D.B., Davis A.K. Micro determination of phospholipids by TCA precipitation. J Lab Clin Med 1950, 35:155-159.
50. Zlatkis A., Zak B., Boyle G.J. A simple method for determination of serum cholesterol. Clin J Med 1953, 41:486-492.